LETTER TO THE EDITOR
COVID-19 Pandemic: Addressing Vaccine Hesitancy Based on Gender
Sharmin Sultana1, Faisal Muhammad1, *, ABM Alauddin Chowdhury1
Identifiers and Pagination:Year: 2022
E-location ID: e187494452201200
Publisher ID: e187494452201200
Article History:Received Date: 23/07/2021
Revision Received Date: 08/11/2021
Acceptance Date: 17/11/2021
Electronic publication date: 14/03/2022
Collection year: 2022
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
One of the best cost-effective ways to prevent diseases is vaccination. The World Health Organization (WHO) has estimated that immunization currently prevents two to three million deaths annually and its widespread coverage could prevent an additional one and a half million deaths . Although the epidemiological and socioeconomic benefits of immunization programs are familiar, the discussion on vaccine hesitancy has grown worldwide. Hesitancy poses a universal risk to the development made in combating vaccine-preventable diseases, becoming a central issue for immunization programs [2-4]. Vaccine hesitancy is described as a delay in acceptance or refusal of vaccination despite the availability of vaccination services . In 2019, vaccine hesitancy was graded as one of the WHO's top ten threats to global health . Vaccines around the world are facing hesitance for different reasons. In 2003, polio vaccine hesitancy was reported in Nigeria , measles vaccine hesitancy in Europe and North America [7, 8], and in 2009, the hesitancy of influenza vaccine was reported . Mostly, government mistrust, fear of side effects, and misinformation are the factors responsible for vaccine hesitancy . Vaccine hesitancy is an obstacle to achieving high vaccination coverage against contagious diseases. Hence, understanding its determinants is essential to help acceptability and tackle vaccine hesitancy .
The novel coronavirus is responsible for causing an infectious disease known as coronavirus disease 2019 (COVID-19) [12-16]. A COVID-19 vaccine is intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing COVID-19. Unfortunately, COVID-19 vaccination programs face an extreme level of vaccine hesitancy worldwide [17, 18]. Thus, notwithstanding great efforts to achieve successful results of COVID-19 vaccines, there may be a significant obstacle to vaccine hesitation regarding approved and potential COVID-19 vaccinations .
A recent study has reported that the female gender has a high percentage of vaccine hesitancy, i.e., 21.0%, compared to 14.7% of the male gender . Similarly, another study established that hesitancy was 19.8% and 13.2% among females and males, respectively . Likewise, the mean (±SD) hesitancy was higher among women (5.08 ± 2.70) than men (4.80 ± 2.66); this was reported in a study conducted in Bangladesh . Females were found six times less likely than males to get a COVID-19 vaccine. However, females were more concerned about becoming sick with coronavirus than males . Women would be more likely than men to wear a mask but less likely to get a COVID-19 vaccine . Nearly 7000 reports processed through the CDC's Vaccine Adverse Event Reporting System revealed that women were accounted for more than 79.0% of all reported adverse events. The most frequent side effects, such as headache, fatigue, and dizziness, were reported . A study said that more side effects from a stronger reaction might contribute to vaccine hesitancy . A survey revealed that women were found to be more likely than men to turn down the shots. They were incredibly anxious about long-term side effects, with nearly three-quarters being extremely or slightly concerned .
Signs of vaccine hesitancy among pregnant women plus those wanting to become pregnant in the future are found by doctors . Pregnant people have additional concerns about how the vaccine might affect their developing fetus. Vaccine acceptance was found to be lower among pregnant women and mothers of young children in the US, Russia, and Australia . Factors unique to reproductive age center on future fertility, current pregnancy, and breastfeeding . Another survey found that about one-fifth (21.0%) of mothers with a dependent kid aged ≤4 admitted were scared of injection due to the possible effects of the jab on their fertility . In December 2020, the first widely shared wrong report about the COVID-19 vaccines and fertility began appearing on social media. Widespread rumors, myths, and misconceptions have been circulated widely on social media, like WhatsApp, Twitter, and Facebook, that SARS-CoV-2 vaccines will result in infertility .
|Fig. (1). Reasons of COVID-19 vaccine hesitancy in women.|
There is no evidence that COVID-19 vaccines affect women's fertility. Based on the current information, the COVID-19 vaccine is safe for pregnant women and breastfeeding mothers [28, 29]. The COVID-19 vaccines do not affect fertility, and there is no evidence reporting that getting vaccinated will injure a mother's baby or disturb someone's ability to conceive . Indeed, the study revealed that COVID-19 antibodies found in mothers' breast milk could be another added advantage to protect the baby . Research on historical data on vaccines revealed that there is never been an instance where a vaccine was responsible for infertility . However, COVID-19 vaccine hesitancy is more common in women than men. Rumors, myths, and misconceptions on infertility are the major causes of COVID19 vaccine hesitancy among women, which implies that public health messaging needs to be informed by the growing feminist literature on the positionality, subjectivity, and situated knowledge of women in the context of personal and social change [30-33]. More studies on COVID-19 vaccination are needed to make women more confident about receiving the vaccine (Fig. 1).
CONFLICT OF INTEREST
The authors declare no conflict of interest, financial or otherwise.
|||World Health Organization (WHO). Ten threats to global health in 2019. 2020. Available from: https://www.who.int/news-room/spotlight/ten-threats-[Accessed on May 28, 2021].|
|||European Centre for Disease Prevention and Control (ECDC). Catalogue of interventions addressing vaccine hesitancy: Technical report. Copenhagen 2017. Available from: https://ecdc.europa.eu/sites/portal/files/documents/Catalogue-interventions-vaccine-hesitancy.pdf[Accessed on April 09, 2021].|
|||The lancet child adolescent health. Vaccine hesitancy: A generation at risk. Lancet Child Adolesc Health 2019; 3(5): 281.
|||Brown AL, Sperandio M, Turssi CP, et al. Vaccine confidence and hesitancy in Brazil. Cad Saude Publica 2018; 34(9): e00011618.
|||MacDonald NE. SAGE working group on vaccine hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015; 33(34): 4161-4.
|||Jegede AS. What led to the Nigerian boycott of the polio vaccination campaign? PLoS Med 2007; 4(3): e73.
|||Hotez PJ, Nuzhath T, Colwell B. Combating vaccine hesitancy and other 21st century social determinants in the global fight against measles. Curr Opin Virol 2020; 41: 1-7.
|||Wilder-Smith AB, Qureshi K. Resurgence of measles in europe: A systematic review on parental attitudes and beliefs of measles vaccine. J Epidemiol Glob Health 2020; 10(1): 46-58.
|||Velan B, Kaplan G, Ziv A, Boyko V, Lerner-Geva L. Major motives in non-acceptance of A/H1N1 flu vaccination: the weight of rational assessment. Vaccine 2011; 29(6): 1173-9.
|||Velan B, Boyko V, Lerner-Geva L, Ziv A, Yagar Y, Kaplan G. Individualism, acceptance and differentiation as attitude traits in the public’s response to vaccination. Hum Vaccin Immunother 2012; 8(9): 1272-82.
|||European Centre for Disease Prevention and Control (ECDC). Key Aspects Regarding the Introduction and Prioritisation of COVID-19 Vaccination in the EU/EEA and the UK. 2020. Available from: https://www.ecdc.europa.eu/en/publications-data/[Accessed on June 01, 2021].|
|||Muhammad F. COVID-19 Pandemic: A Threat to a Diabetic Patient. Open Public Health J 2021; 13(1): 404.
|||Adam AS. U. Abdilahi UA, Abubakar IM, Muhammad F. COVID-19 Pandemic: The Role of Strong Immunity. OIRT J Sci Res 2021; 1(2): 36-8.
|||Muhammad F, Rahman AB, Oruche CA, Musa AA, Abdulkarim JH. COVID-19 pandemic: Issues and challenges in the psychiatric sector. OIRT J Med and Health Sci 2021; 1(1): 19-21.
|||Joseph SA, Musa AA, Muhammad F, Ahmad TM. COVID-19 pandemic: A global disaster. OIRT J Hum Soc Sci 2021; 1(1): 7-8.
|||Abdulkarim JH, Muhammad F. Factors that hindered effective containment of coronavirus: A Nigerian perspective. Open Epidemiol J 2021; 9(1): 1-2.
|||Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: implications for public health communications. Lancet Reg Heal - Eur 2021; 1: 100012.
|||Sallam M. COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines (Basel) 2021; 9(2): 160.
|||Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol 2020; 35(4): 325-30.
|||Robertson E, Reeve KS, Niedzwiedz CL, et al. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav Immun 2021; 94: 41-50.
|||Oliveira BLCAde, Campos MAG, QueirozRCdeS, Britto e Alves MTSSde, Souza BFde, Santos AMdos, Silva AAMda. Prevalence and factors associated with covid-19 vaccine hesitancy in Maranhão, Brazil. Rev Saude Publica 2021; 55: 12.
|||Hossain MB, Alam MZ, Islam MS, et al. COVID-19 vaccine hesitancy among the adult population in Bangladesh: A nationally representative cross-sectional survey medRxiv 2021; 21255844.
|||The Washington Post. Why might women be less eager to get the coronavirus vaccine? An investigation 2020. Available from: https://www.washingtonpost.com/lifestyle/style/women-covid-vaccine skeptical/2020/12/15/63551cac-3a61-11eb-9276-ae0ca72729be_story.html [Accessed on June 1, 2021].|
|||Rodriquez A. Women report more side effects from the COVID-19 vaccine than men. Health experts explain why. 2021. Available from: https://www.usatoday.com/story/news/health/2021/04/10/covid-vaccine-women-report-more-side-effects-than-men-heres-why/7139366002/ [Accessed on June 2, 2021].|
|||The Washington Post. False claims tying coronavirus vaccines to infertility drive doubts among women of childbearing age 2021. Available from: https://www.healthleadersmedia.com/covid-19/false-claims-tying-coronavirus-vaccines-infertility-drive-doubts-among-women-childbearing [Accessed on April 2, 2021].|
|||Haas E. Medical experts: COVID-19 vaccines do not impact fertility 2021. Available from: https://www.koin.com/news/health/coronavirus/doctors-see-vaccine-hesitancy-among-pregnant-women/ [Accessed on May 2, 2021].|
|||Skjefte M, Ngirbabul M, Akeju O, et al. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. Eur J Epidemiol 2021; 36(2): 197-211.
|||Rimmer A. Covid-19: Breastfeeding women can have vaccine after guidance turnaround. BMJ 2021; 372(64): n64.
|||Ceulemans M, Verbakel JY, Van Calsteren K, Eerdekens A, Allegaert K, Foulon V. SARS-CoV-2 infections and impact of the COVID-19 pandemic in pregnancy and breastfeeding: Results from an observational study in primary care in Belgium. Int J Environ Res Public Health 2020; 17(18): 6766.
|||Simandan D. Being surprised and surprising ourselves: A geography of personal and social change. Prog Hum Geogr 2020; 44(1): 99-118.
|||Simandan D. Rethinking the health consequences of social class and social mobility. Soc Sci Med 2018; 200: 258-61.
|||Simandan D. Proximity, subjectivity, and space: Rethinking distance in human geography. Geoforum 2016; 75: 249-52.
|||Simandan D. Revisiting positionality and the thesis of situated knowledge. Dialogues in human geography 2019; 9(2): 129-49.|